Clinical Trials on Chronic Stable Plaque Psoriasis in Canada
Total 267 results
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLRecruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
Merck KGaA, Darmstadt, GermanyTerminated
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
MedImmune LLCCompletedChronic Plaque PsoriasisCanada
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Escalier Biosciences B.V.Innovaderm Research Inc.CompletedPsoriatic PlaqueUnited States, Canada
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Galderma R&DCompletedChronic Plaque PsoriasisUnited States, Canada
-
Astellas Pharma IncCompletedChronic Plaque PsoriasisUnited States, Canada
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Terminated
-
AbbVieCompletedChronic Plaque PsoriasisUnited States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
-
PfizerCompletedChronic Plaque PsoriasisUnited States, Poland, Canada
-
Astellas Pharma IncBiogenCompletedChronic Plaque PsoriasisUnited States, Austria, Germany, Belgium, Canada
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
Forward-Pharma GmbHWithdrawnPlaque PsoriasisCanada
-
Kineta Inc.Completed
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States, Estonia, Japan, Latvia, Canada, Iceland
-
UCB Biopharma S.P.R.L.ParexelCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
AbbVieActive, not recruitingChronic Plaque PsoriasisArgentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Innovaderm Research Inc.Recruiting
-
Dermatrials ResearchAmgenCompletedPlaque PsoriasisCanada
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada
-
BiogenCompletedChronic Plaque PsoriasisUnited States, Germany, France, Canada, Austria, Denmark, Netherlands, Switzerland, United Kingdom
-
Momenta Pharmaceuticals, Inc.CompletedPsoriasis | Chronic Plaque PsoriasisUnited States, Poland, Canada, Czechia, Estonia, Germany, Slovakia, Bulgaria, Latvia
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
Merck KGaA, Darmstadt, GermanyTerminatedPlaque PsoriasisCanada
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Astellas Pharma IncBiogenCompletedChronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
AbbottCompletedChronic Plaque PsoriasisBelgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
-
Akros Pharma Inc.CompletedSkin Diseases | Psoriasis | Plaque PsoriasisCanada
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Galderma R&DCompletedPlaque PsoriasisUnited States, Canada
-
Innovaderm Research Inc.AbbottCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
PRCL Research Inc.CompletedPlaque Psoriasis | Psoriasis VulgarisCanada, Slovakia, Ukraine
-
ApoPharmaCompletedPlaque PsoriasisUnited States, Canada
-
TakedaCompleted
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Canada, Germany, France, Spain, Poland
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
-
Arcutis Biotherapeutics, Inc.CompletedMaximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)Psoriasis | Plaque PsoriasisUnited States, Canada, Dominican Republic